Sunday, November 8, 2026

USD/CNH Bullish By 1% In The Last 10 Sessions

ViaNews Editorial Team

October 11, 2024

USD/CNH Bullish By 1% In The Last 10 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 1.44% for the last 10 sessions. At 08:07 EST on Friday, 11 October, USD/CNH (USDCNH) is $7.07.

USD/CNH's yearly highs and lows, it's 0.058% up from its 52-week low and 0.226% down from its 52-week high.

News about

  • According to FXStreet on Wednesday, 9 October, "We continue to flat-line our multi-quarter EUR/USD forecasts at 1.10 until the outcome ofNovember's US presidential election is known.", "There is very little on the eurozone calendar today and while EUR/USD may press 1.10on the back of this morning's news out of China -the Ministry of Finance will brief on fiscal policy this Saturday -we suspect sellers to emerge there."
  • Eur/usd hangs near two-month low, seems vulnerable below mid-1.0900s ahead of US CPI. According to FXStreet on Thursday, 10 October, "Moreover, the risk of a further escalation of geopolitical tensions in the Middle East should benefit the safe-haven Greenback and suggest that the path of least resistance for the EUR/USD pair is to the downside. ", "The data will play a key role in influencing expectations about the Fed's rate-cut path, which, in turn, will drive the USD demand in the near term and provide a fresh directional impetus to the EUR/USD pair."
  • Eur/usd falls back as US CPI inflation data prints above expectations. According to FXStreet on Thursday, 10 October, "The EUR/USD pair is trading around 1.09343, experiencing a slight decline of 0.05% for the day as selling pressure continues to weigh on the currency pair. "
  • Eur/usd struggles to gain ground below 1.0950 ahead of German inflation data. According to FXStreet on Friday, 11 October, "The EUR/USD pair remains on the defensive around 1.0935 during the early European session on Friday. "

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com